BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29970140)

  • 1. Fulminant hepatitis due to very severe sinusoidal obstruction syndrome (SOS/VOD) after autologous peripheral stem cell transplantation: a case report.
    Tavernier E; Chalayer E; Cornillon J; Pouvaret A; Martignoles JA; Casteillo F; Terreaux J; Daguenet E; Guyotat D
    BMC Res Notes; 2018 Jul; 11(1):436. PubMed ID: 29970140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinusoidal obstruction syndrome/veno-occlusive disease complication in lymphoma patients treated with oxaliplatin-based regimen: A case series report.
    Bernichon E; Daguenet E; Molla C; Cornillon J; Lejeune C; Casteillo F; Guyotat D; Tavernier E
    Curr Res Transl Med; 2018 Nov; 66(4):107-110. PubMed ID: 29519713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
    Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
    Corbacioglu S; Jabbour EJ; Mohty M
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1271-1280. PubMed ID: 30797942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
    Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
    Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
    Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study.
    Putta S; Young BA; Levine JE; Reshef R; Nakamura R; Strouse C; Perales MA; Howard A; Pine P; Shi J; Zhang P; Ho VT; Saber W
    Transplant Cell Ther; 2023 Mar; 29(3):166.e1-166.e10. PubMed ID: 36574581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of sinusoidal obstruction syndrome (veno-occlusive disease)].
    Kikuta A
    Rinsho Ketsueki; 2021; 62(8):1256-1264. PubMed ID: 34497214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Eelated to Hematopoietic Stem Cell Transplantation
.
    Ní Chonghaile M; Wolownik K
    Clin J Oncol Nurs; 2018 Feb; 22(1):E7-E17. PubMed ID: 29350698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
    Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A
    Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
    Dalle JH; Giralt SA
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
    Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Lai X; Liu L; Zhang Z; Shi L; Yang G; Wu M; Huang R; Liu R; Lai Y; Li Q
    Bone Marrow Transplant; 2021 Jul; 56(7):1635-1641. PubMed ID: 33608657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
    Ho VT; Martin AS; Pérez WS; Steinert P; Zhang MJ; Chirnomas D; Hoang CJ; Loberiza FR; Saber W
    Biol Blood Marrow Transplant; 2020 May; 26(5):884-892. PubMed ID: 31891815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).
    Fan CQ; Crawford JM
    J Clin Exp Hepatol; 2014 Dec; 4(4):332-46. PubMed ID: 25755580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.
    Sebagh M; Azoulay D; Roche B; Hoti E; Karam V; Teicher E; Bonhomme-Faivre L; Saliba F; Duclos-Vallée JC; Samuel D
    Liver Transpl; 2011 Jul; 17(7):798-808. PubMed ID: 21351239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Cryopreserved CD34
    Kato S; Konuma T; Monna-Oiwa M; Isobe M; Takahashi S; Nannya Y
    Transplant Cell Ther; 2022 Nov; 28(11):779.e1-779.e9. PubMed ID: 35995391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.